Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GLI3
|
ENSG00000106571.15 | GLI family zinc finger 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLI3 | hg38_v1_chr7_-_42237059_42237183 | 0.52 | 2.2e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_85668172 | 6.91 |
ENST00000428225.5
ENST00000519937.7 |
SFTPB
|
surfactant protein B |
chr15_+_81299416 | 4.23 |
ENST00000558332.3
|
IL16
|
interleukin 16 |
chr14_-_106557465 | 3.39 |
ENST00000390625.3
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr2_-_136118142 | 3.38 |
ENST00000241393.4
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
chr14_-_106335613 | 3.28 |
ENST00000603660.1
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr22_+_22409755 | 3.28 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr14_-_106627685 | 3.11 |
ENST00000390629.3
|
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr19_+_44914588 | 3.02 |
ENST00000592535.6
|
APOC1
|
apolipoprotein C1 |
chr19_+_18173148 | 3.00 |
ENST00000597802.2
|
IFI30
|
IFI30 lysosomal thiol reductase |
chr3_+_32951636 | 2.99 |
ENST00000330953.6
|
CCR4
|
C-C motif chemokine receptor 4 |
chr6_-_132763424 | 2.96 |
ENST00000532012.1
ENST00000525270.5 ENST00000530536.5 ENST00000524919.5 |
VNN2
|
vanin 2 |
chr19_+_44914702 | 2.92 |
ENST00000592885.5
ENST00000589781.1 |
APOC1
|
apolipoprotein C1 |
chr5_-_180591488 | 2.81 |
ENST00000292641.4
|
SCGB3A1
|
secretoglobin family 3A member 1 |
chr21_-_44910630 | 2.70 |
ENST00000320216.10
ENST00000397852.5 |
ITGB2
|
integrin subunit beta 2 |
chr14_-_106639589 | 2.61 |
ENST00000390630.3
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr14_-_106374129 | 2.60 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr19_+_44914833 | 2.55 |
ENST00000589078.1
ENST00000586638.5 |
APOC1
|
apolipoprotein C1 |
chr1_-_161021096 | 2.39 |
ENST00000537746.1
ENST00000368026.11 |
F11R
|
F11 receptor |
chr8_-_6938301 | 2.37 |
ENST00000297435.3
|
DEFA4
|
defensin alpha 4 |
chr22_-_50532137 | 2.33 |
ENST00000405135.5
ENST00000401779.5 ENST00000682240.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr14_-_106108453 | 2.29 |
ENST00000632950.2
|
IGHV5-10-1
|
immunoglobulin heavy variable 5-10-1 |
chr14_-_106360320 | 2.28 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr2_-_85663393 | 2.25 |
ENST00000494165.1
|
SFTPB
|
surfactant protein B |
chr16_-_85112390 | 2.20 |
ENST00000629253.1
ENST00000539556.6 |
CIBAR2
|
CBY1 interacting BAR domain containing 2 |
chr19_+_44914247 | 2.16 |
ENST00000588750.5
ENST00000588802.5 |
APOC1
|
apolipoprotein C1 |
chr12_-_10390023 | 2.14 |
ENST00000240618.11
|
KLRK1
|
killer cell lectin like receptor K1 |
chr14_-_106324743 | 2.05 |
ENST00000390612.3
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr22_-_19524400 | 2.03 |
ENST00000618236.2
|
CLDN5
|
claudin 5 |
chr8_-_6999198 | 2.03 |
ENST00000382689.8
|
DEFA1B
|
defensin alpha 1B |
chr19_-_54280498 | 2.02 |
ENST00000391746.5
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr12_-_44876294 | 2.00 |
ENST00000429094.7
ENST00000551601.5 ENST00000549027.5 ENST00000452445.6 |
NELL2
|
neural EGFL like 2 |
chr14_-_106593319 | 1.97 |
ENST00000390627.3
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr14_-_106154113 | 1.92 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr12_-_11310420 | 1.92 |
ENST00000621732.4
ENST00000445719.2 ENST00000279575.7 |
PRB4
|
proline rich protein BstNI subfamily 4 |
chr16_+_57668299 | 1.89 |
ENST00000333493.9
ENST00000450388.7 |
ADGRG3
|
adhesion G protein-coupled receptor G3 |
chr6_-_46735351 | 1.85 |
ENST00000274793.12
|
PLA2G7
|
phospholipase A2 group VII |
chr19_+_54630960 | 1.84 |
ENST00000396317.5
ENST00000396315.5 |
LILRB1
|
leukocyte immunoglobulin like receptor B1 |
chr8_-_81112055 | 1.81 |
ENST00000220597.4
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
chr19_-_54222978 | 1.75 |
ENST00000245620.13
ENST00000346401.10 ENST00000445347.1 |
LILRB3
|
leukocyte immunoglobulin like receptor B3 |
chr19_+_18173804 | 1.74 |
ENST00000407280.4
|
IFI30
|
IFI30 lysosomal thiol reductase |
chr1_-_21279520 | 1.73 |
ENST00000357071.8
|
ECE1
|
endothelin converting enzyme 1 |
chr22_+_22904850 | 1.73 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr21_-_44928824 | 1.72 |
ENST00000355153.8
ENST00000397850.6 |
ITGB2
|
integrin subunit beta 2 |
chr22_+_22887780 | 1.68 |
ENST00000532223.2
ENST00000526893.6 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda like polypeptide 5 |
chr16_+_30182969 | 1.64 |
ENST00000561815.5
|
CORO1A
|
coronin 1A |
chr6_-_46735693 | 1.62 |
ENST00000537365.1
|
PLA2G7
|
phospholipase A2 group VII |
chr14_-_106301848 | 1.61 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr16_+_165966 | 1.60 |
ENST00000356815.4
|
HBM
|
hemoglobin subunit mu |
chr22_+_22322452 | 1.59 |
ENST00000390290.3
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr2_-_86861871 | 1.59 |
ENST00000390655.12
ENST00000393759.6 ENST00000349455.7 ENST00000331469.6 ENST00000393761.6 ENST00000431506.3 |
CD8B
|
CD8b molecule |
chr14_-_94390614 | 1.58 |
ENST00000553327.5
ENST00000556955.5 ENST00000557118.5 ENST00000440909.5 |
SERPINA1
|
serpin family A member 1 |
chr16_+_28984795 | 1.57 |
ENST00000395461.7
|
LAT
|
linker for activation of T cells |
chr14_-_94390667 | 1.56 |
ENST00000557492.5
ENST00000355814.8 ENST00000437397.5 ENST00000448921.5 ENST00000393088.8 |
SERPINA1
|
serpin family A member 1 |
chr22_+_22098683 | 1.56 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr1_-_161631032 | 1.56 |
ENST00000534776.1
ENST00000613418.4 ENST00000614870.4 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr1_-_47231715 | 1.55 |
ENST00000371884.6
|
TAL1
|
TAL bHLH transcription factor 1, erythroid differentiation factor |
chr22_-_41926791 | 1.52 |
ENST00000291232.5
|
TNFRSF13C
|
TNF receptor superfamily member 13C |
chr20_+_46008900 | 1.50 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr14_-_94390650 | 1.49 |
ENST00000449399.7
ENST00000404814.8 |
SERPINA1
|
serpin family A member 1 |
chr1_+_65525641 | 1.47 |
ENST00000344610.12
ENST00000616738.4 |
LEPR
|
leptin receptor |
chr6_-_24910695 | 1.47 |
ENST00000643623.1
ENST00000538035.6 ENST00000647136.1 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr16_+_85914267 | 1.47 |
ENST00000569607.1
|
IRF8
|
interferon regulatory factor 8 |
chr19_-_41353044 | 1.46 |
ENST00000600196.2
ENST00000677934.1 |
TGFB1
|
transforming growth factor beta 1 |
chr16_+_28985043 | 1.45 |
ENST00000395456.7
ENST00000564277.5 ENST00000630764.2 ENST00000354453.7 |
LAT
|
linker for activation of T cells |
chr1_+_1001002 | 1.45 |
ENST00000624697.4
ENST00000624652.1 |
ISG15
|
ISG15 ubiquitin like modifier |
chr22_+_22375984 | 1.44 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr22_+_36863091 | 1.44 |
ENST00000650698.1
|
NCF4
|
neutrophil cytosolic factor 4 |
chr6_-_32816910 | 1.42 |
ENST00000447394.1
ENST00000438763.7 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr1_-_161631152 | 1.42 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr1_+_17308194 | 1.41 |
ENST00000375453.5
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase 4 |
chr14_-_24634160 | 1.41 |
ENST00000616551.1
ENST00000382542.5 ENST00000216341.9 ENST00000526004.1 ENST00000415355.7 |
GZMB
|
granzyme B |
chr16_+_30183595 | 1.39 |
ENST00000219150.10
ENST00000570045.5 ENST00000565497.5 ENST00000570244.5 |
CORO1A
|
coronin 1A |
chr6_-_30932147 | 1.37 |
ENST00000359086.4
|
SFTA2
|
surfactant associated 2 |
chr6_-_73523757 | 1.37 |
ENST00000455918.2
ENST00000677236.1 |
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr4_+_2829797 | 1.35 |
ENST00000513069.1
|
SH3BP2
|
SH3 domain binding protein 2 |
chr20_+_63696643 | 1.35 |
ENST00000369996.3
|
TNFRSF6B
|
TNF receptor superfamily member 6b |
chr17_-_6831716 | 1.35 |
ENST00000338694.7
|
TEKT1
|
tektin 1 |
chr11_-_414948 | 1.34 |
ENST00000530494.1
ENST00000528209.5 ENST00000528058.1 ENST00000431843.7 |
SIGIRR
|
single Ig and TIR domain containing |
chr16_+_30182795 | 1.34 |
ENST00000563778.5
|
CORO1A
|
coronin 1A |
chr7_+_142626642 | 1.33 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
chr1_+_26543106 | 1.33 |
ENST00000530003.5
|
RPS6KA1
|
ribosomal protein S6 kinase A1 |
chr4_-_5019437 | 1.32 |
ENST00000506508.1
ENST00000509419.1 ENST00000307746.9 |
CYTL1
|
cytokine like 1 |
chr6_+_137871208 | 1.31 |
ENST00000614035.4
ENST00000621150.3 ENST00000619035.4 ENST00000615468.4 ENST00000620204.3 |
TNFAIP3
|
TNF alpha induced protein 3 |
chr19_+_44748673 | 1.31 |
ENST00000164227.10
|
BCL3
|
BCL3 transcription coactivator |
chr5_+_157142933 | 1.30 |
ENST00000521769.5
|
ITK
|
IL2 inducible T cell kinase |
chr19_+_54874218 | 1.29 |
ENST00000355524.8
ENST00000391726.7 |
FCAR
|
Fc fragment of IgA receptor |
chr3_-_46464868 | 1.25 |
ENST00000417439.5
ENST00000231751.9 ENST00000431944.1 |
LTF
|
lactotransferrin |
chr19_+_54874275 | 1.25 |
ENST00000469767.5
ENST00000391725.7 ENST00000345937.8 ENST00000353758.8 ENST00000359272.8 ENST00000391723.7 ENST00000391724.3 |
FCAR
|
Fc fragment of IgA receptor |
chr16_+_3065348 | 1.24 |
ENST00000529699.5
ENST00000526464.6 ENST00000440815.7 ENST00000529550.5 |
IL32
|
interleukin 32 |
chr12_-_57488726 | 1.24 |
ENST00000550288.6
ENST00000393797.7 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chrX_-_1537165 | 1.22 |
ENST00000381297.10
|
P2RY8
|
P2Y receptor family member 8 |
chrX_-_102516714 | 1.22 |
ENST00000289373.5
|
TMSB15A
|
thymosin beta 15A |
chr19_-_19643597 | 1.21 |
ENST00000587205.1
ENST00000203556.9 |
GMIP
|
GEM interacting protein |
chr16_+_2830155 | 1.21 |
ENST00000382280.7
|
ZG16B
|
zymogen granule protein 16B |
chr11_+_1868673 | 1.21 |
ENST00000405957.6
|
LSP1
|
lymphocyte specific protein 1 |
chrX_-_47629845 | 1.21 |
ENST00000469388.1
ENST00000396992.8 ENST00000377005.6 |
CFP
|
complement factor properdin |
chr7_+_142615710 | 1.20 |
ENST00000611520.1
|
TRBV18
|
T cell receptor beta variable 18 |
chr22_-_50532077 | 1.19 |
ENST00000428989.3
ENST00000403326.5 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr7_+_142352802 | 1.18 |
ENST00000634605.1
|
TRBV7-2
|
T cell receptor beta variable 7-2 |
chr16_-_11587162 | 1.18 |
ENST00000570904.5
ENST00000574701.5 |
LITAF
|
lipopolysaccharide induced TNF factor |
chr20_+_38304149 | 1.17 |
ENST00000262865.9
ENST00000642449.2 |
BPI
|
bactericidal permeability increasing protein |
chr17_-_48430205 | 1.17 |
ENST00000336915.11
ENST00000584924.5 |
SKAP1
|
src kinase associated phosphoprotein 1 |
chrX_+_48683763 | 1.17 |
ENST00000376701.5
|
WAS
|
WASP actin nucleation promoting factor |
chr19_-_54242751 | 1.17 |
ENST00000245621.6
ENST00000396365.6 |
LILRA6
|
leukocyte immunoglobulin like receptor A6 |
chr11_+_1870871 | 1.15 |
ENST00000417766.5
|
LSP1
|
lymphocyte specific protein 1 |
chr1_+_27879638 | 1.14 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr17_-_3916455 | 1.12 |
ENST00000225538.4
|
P2RX1
|
purinergic receptor P2X 1 |
chr13_-_46182136 | 1.11 |
ENST00000323076.7
|
LCP1
|
lymphocyte cytosolic protein 1 |
chr12_+_6946468 | 1.11 |
ENST00000543115.5
ENST00000399448.5 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
chr19_+_35000426 | 1.10 |
ENST00000411896.6
ENST00000424536.2 |
GRAMD1A
|
GRAM domain containing 1A |
chr19_-_11577632 | 1.10 |
ENST00000590420.1
ENST00000648477.1 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr8_-_130016536 | 1.09 |
ENST00000519020.5
|
CYRIB
|
CYFIP related Rac1 interactor B |
chr22_-_50526337 | 1.09 |
ENST00000651490.1
ENST00000543927.6 |
TYMP
SCO2
|
thymidine phosphorylase synthesis of cytochrome C oxidase 2 |
chr4_+_153684241 | 1.08 |
ENST00000646219.1
ENST00000642580.1 ENST00000643501.1 ENST00000642700.2 |
TLR2
|
toll like receptor 2 |
chr17_+_83079595 | 1.08 |
ENST00000320095.12
|
METRNL
|
meteorin like, glial cell differentiation regulator |
chr1_-_212699817 | 1.07 |
ENST00000243440.2
|
BATF3
|
basic leucine zipper ATF-like transcription factor 3 |
chr6_+_33080445 | 1.06 |
ENST00000428835.5
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr20_+_3796288 | 1.04 |
ENST00000439880.6
ENST00000245960.10 |
CDC25B
|
cell division cycle 25B |
chr7_+_142715314 | 1.04 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
chr16_-_11587450 | 1.04 |
ENST00000571688.5
|
LITAF
|
lipopolysaccharide induced TNF factor |
chr21_-_34888683 | 1.03 |
ENST00000344691.8
ENST00000358356.9 |
RUNX1
|
RUNX family transcription factor 1 |
chr9_-_114387973 | 1.02 |
ENST00000374088.8
|
AKNA
|
AT-hook transcription factor |
chr9_+_92947516 | 1.02 |
ENST00000375482.8
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3 |
chr14_+_61321571 | 1.01 |
ENST00000332981.11
|
PRKCH
|
protein kinase C eta |
chr1_-_110674919 | 1.01 |
ENST00000369769.4
|
KCNA3
|
potassium voltage-gated channel subfamily A member 3 |
chr19_+_17527250 | 1.00 |
ENST00000599164.6
ENST00000449408.6 ENST00000600871.5 ENST00000599124.1 |
NIBAN3
|
niban apoptosis regulator 3 |
chr12_-_56636318 | 0.99 |
ENST00000549506.5
ENST00000379441.7 ENST00000551812.5 |
BAZ2A
|
bromodomain adjacent to zinc finger domain 2A |
chr9_-_136996555 | 0.99 |
ENST00000494426.2
|
CLIC3
|
chloride intracellular channel 3 |
chr22_-_36365036 | 0.98 |
ENST00000456729.1
ENST00000401701.1 |
MYH9
|
myosin heavy chain 9 |
chr16_+_28985251 | 0.98 |
ENST00000360872.9
ENST00000566177.5 |
LAT
|
linker for activation of T cells |
chr2_+_130611440 | 0.98 |
ENST00000409602.2
|
POTEJ
|
POTE ankyrin domain family member J |
chr9_+_69820827 | 0.98 |
ENST00000527647.5
ENST00000480564.1 |
C9orf135
|
chromosome 9 open reading frame 135 |
chr19_-_11578937 | 0.98 |
ENST00000592659.1
ENST00000592828.6 ENST00000218758.9 ENST00000412435.6 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr19_-_19643547 | 0.97 |
ENST00000587238.5
|
GMIP
|
GEM interacting protein |
chr22_-_50532489 | 0.97 |
ENST00000329363.9
ENST00000437588.2 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr19_-_54281145 | 0.97 |
ENST00000434421.5
ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr1_+_160796098 | 0.96 |
ENST00000392203.8
|
LY9
|
lymphocyte antigen 9 |
chr19_-_18086904 | 0.96 |
ENST00000322153.11
ENST00000593993.7 |
IL12RB1
|
interleukin 12 receptor subunit beta 1 |
chr16_-_67999468 | 0.95 |
ENST00000393847.6
ENST00000573808.1 ENST00000572624.5 |
DPEP2
|
dipeptidase 2 |
chr1_+_48222685 | 0.94 |
ENST00000533824.5
ENST00000236495.9 ENST00000438567.7 |
SLC5A9
|
solute carrier family 5 member 9 |
chr6_-_109455698 | 0.94 |
ENST00000431946.1
ENST00000358577.7 ENST00000358807.8 |
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr16_+_1256059 | 0.94 |
ENST00000397534.6
ENST00000211076.5 |
TPSD1
|
tryptase delta 1 |
chr5_-_180809811 | 0.93 |
ENST00000446023.6
|
MGAT1
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
chr12_-_52493250 | 0.93 |
ENST00000330722.7
|
KRT6A
|
keratin 6A |
chr19_+_5914202 | 0.93 |
ENST00000588776.8
ENST00000588865.2 |
CAPS
|
calcyphosine |
chr2_+_26692686 | 0.93 |
ENST00000620977.1
ENST00000302909.4 |
KCNK3
|
potassium two pore domain channel subfamily K member 3 |
chr20_-_22585451 | 0.93 |
ENST00000377115.4
|
FOXA2
|
forkhead box A2 |
chr19_+_53869439 | 0.92 |
ENST00000391768.2
|
MYADM
|
myeloid associated differentiation marker |
chr17_-_64390592 | 0.92 |
ENST00000563523.5
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1 |
chr20_+_50190821 | 0.92 |
ENST00000303004.5
|
CEBPB
|
CCAAT enhancer binding protein beta |
chr11_-_128587551 | 0.91 |
ENST00000392668.8
|
ETS1
|
ETS proto-oncogene 1, transcription factor |
chr14_-_106389858 | 0.91 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr2_-_201071579 | 0.90 |
ENST00000453765.5
ENST00000452799.5 ENST00000446678.5 ENST00000418596.7 ENST00000681958.1 |
FAM126B
|
family with sequence similarity 126 member B |
chr20_-_22584547 | 0.90 |
ENST00000419308.7
|
FOXA2
|
forkhead box A2 |
chr19_-_38735405 | 0.90 |
ENST00000597987.5
ENST00000595177.1 |
CAPN12
|
calpain 12 |
chr18_+_24014390 | 0.89 |
ENST00000584250.1
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr17_-_64398391 | 0.89 |
ENST00000569967.1
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1 |
chr14_-_106791226 | 0.89 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr5_-_180810086 | 0.88 |
ENST00000506889.1
ENST00000393340.7 |
MGAT1
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
chr1_+_209768482 | 0.88 |
ENST00000367023.5
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr14_+_20955484 | 0.88 |
ENST00000304625.3
|
RNASE2
|
ribonuclease A family member 2 |
chr16_-_89201635 | 0.87 |
ENST00000562855.7
|
SLC22A31
|
solute carrier family 22 member 31 |
chr18_+_23949847 | 0.87 |
ENST00000588004.1
|
LAMA3
|
laminin subunit alpha 3 |
chr15_+_90184912 | 0.87 |
ENST00000561085.1
ENST00000332496.10 |
SEMA4B
|
semaphorin 4B |
chr20_-_23988779 | 0.87 |
ENST00000335694.4
|
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
chrX_+_107206605 | 0.86 |
ENST00000372453.8
|
DNAAF6
|
dynein axonemal assembly factor 6 |
chr9_-_114388020 | 0.86 |
ENST00000312033.3
|
AKNA
|
AT-hook transcription factor |
chr12_-_10882602 | 0.86 |
ENST00000538332.2
|
PRH1
|
proline rich protein HaeIII subfamily 1 |
chr16_+_50693568 | 0.86 |
ENST00000647318.2
ENST00000531674.1 |
NOD2
|
nucleotide binding oligomerization domain containing 2 |
chr11_+_46381645 | 0.85 |
ENST00000617138.4
ENST00000395566.9 ENST00000395569.8 |
MDK
|
midkine |
chr20_+_833705 | 0.85 |
ENST00000381941.8
|
FAM110A
|
family with sequence similarity 110 member A |
chr3_-_72446623 | 0.85 |
ENST00000477973.4
|
RYBP
|
RING1 and YY1 binding protein |
chr12_+_6772512 | 0.85 |
ENST00000441671.6
ENST00000203629.3 |
LAG3
|
lymphocyte activating 3 |
chr19_-_48617797 | 0.85 |
ENST00000546623.5
ENST00000084795.9 |
RPL18
|
ribosomal protein L18 |
chr1_+_156153568 | 0.85 |
ENST00000368284.5
ENST00000368286.6 ENST00000368285.8 ENST00000438830.5 |
SEMA4A
|
semaphorin 4A |
chr19_+_6887560 | 0.84 |
ENST00000250572.12
ENST00000381407.9 ENST00000450315.7 ENST00000312053.9 ENST00000381404.8 |
ADGRE1
|
adhesion G protein-coupled receptor E1 |
chr16_-_4416621 | 0.83 |
ENST00000570645.5
ENST00000574025.5 ENST00000572898.1 ENST00000537233.6 ENST00000571059.5 |
CORO7
|
coronin 7 |
chr20_+_2207217 | 0.83 |
ENST00000447956.5
ENST00000411839.1 ENST00000651531.1 |
ENSG00000226644.5
ENSG00000286022.1
|
novel transcript novel protein |
chr14_-_24634266 | 0.83 |
ENST00000382540.5
|
GZMB
|
granzyme B |
chr20_+_833734 | 0.83 |
ENST00000304189.6
|
FAM110A
|
family with sequence similarity 110 member A |
chr12_-_54419259 | 0.82 |
ENST00000293379.9
|
ITGA5
|
integrin subunit alpha 5 |
chr17_+_10697576 | 0.82 |
ENST00000379774.5
|
ADPRM
|
ADP-ribose/CDP-alcohol diphosphatase, manganese dependent |
chr2_-_196171565 | 0.82 |
ENST00000263955.9
|
STK17B
|
serine/threonine kinase 17b |
chr9_-_127762416 | 0.82 |
ENST00000440630.5
ENST00000429553.5 |
SH2D3C
|
SH2 domain containing 3C |
chr5_-_180815563 | 0.82 |
ENST00000513431.5
ENST00000514438.1 |
MGAT1
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
chr19_-_10335773 | 0.82 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr6_-_166956561 | 0.82 |
ENST00000366855.10
|
RNASET2
|
ribonuclease T2 |
chr17_-_41140487 | 0.81 |
ENST00000345847.4
|
KRTAP4-6
|
keratin associated protein 4-6 |
chr19_+_40611863 | 0.81 |
ENST00000601032.5
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr19_-_54281082 | 0.81 |
ENST00000314446.10
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr19_+_7355589 | 0.81 |
ENST00000671891.2
|
ARHGEF18
|
Rho/Rac guanine nucleotide exchange factor 18 |
chr4_-_176792913 | 0.81 |
ENST00000618562.2
|
VEGFC
|
vascular endothelial growth factor C |
chr20_+_841238 | 0.81 |
ENST00000541082.2
|
FAM110A
|
family with sequence similarity 110 member A |
chr7_-_41703062 | 0.81 |
ENST00000242208.5
|
INHBA
|
inhibin subunit beta A |
chr21_+_33432173 | 0.80 |
ENST00000421802.1
|
IFNGR2
|
interferon gamma receptor 2 |
chr19_+_19668809 | 0.80 |
ENST00000592502.2
ENST00000444249.6 |
ZNF101
|
zinc finger protein 101 |
chr17_-_49209367 | 0.80 |
ENST00000300406.6
ENST00000511277.5 ENST00000511673.1 |
GNGT2
|
G protein subunit gamma transducin 2 |
chr16_-_88703611 | 0.80 |
ENST00000541206.6
|
RNF166
|
ring finger protein 166 |
chr17_+_47253817 | 0.79 |
ENST00000559488.7
ENST00000571680.1 |
ITGB3
|
integrin subunit beta 3 |
chr1_+_103749654 | 0.79 |
ENST00000683532.1
|
AMY1C
|
amylase alpha 1C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 10.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.1 | 5.3 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 2.2 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.7 | 5.6 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.6 | 3.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.5 | 1.6 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.5 | 4.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.5 | 1.6 | GO:0030221 | basophil differentiation(GO:0030221) |
0.5 | 1.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.5 | 1.9 | GO:0032595 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
0.5 | 1.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.5 | 3.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 1.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.4 | 1.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 1.5 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.4 | 2.2 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.4 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 2.5 | GO:0030421 | defecation(GO:0030421) |
0.3 | 3.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 1.3 | GO:0070429 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.3 | 1.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.3 | 0.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 2.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 0.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 2.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 0.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 1.7 | GO:2000784 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.2 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 1.7 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 1.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.9 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
0.2 | 1.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 1.8 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 1.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 36.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.9 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.2 | 0.9 | GO:0035419 | detection of peptidoglycan(GO:0032499) activation of MAPK activity involved in innate immune response(GO:0035419) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.9 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.2 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.6 | GO:0039521 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) modulation by virus of host autophagy(GO:0039519) suppression by virus of host autophagy(GO:0039521) |
0.2 | 0.6 | GO:0061011 | hepatic duct development(GO:0061011) |
0.2 | 1.2 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.2 | 1.0 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 5.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.2 | 1.0 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.2 | 1.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.5 | GO:0032701 | negative regulation of interleukin-18 production(GO:0032701) |
0.2 | 3.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 1.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 4.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.2 | 0.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 0.5 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.2 | 0.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 2.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 2.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 2.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.3 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.2 | 1.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 0.5 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.2 | 1.5 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.6 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 3.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.6 | GO:0060928 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.1 | 0.8 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
0.1 | 1.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 1.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.7 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.5 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 1.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.7 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 0.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 0.3 | GO:1904000 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) positive regulation of eating behavior(GO:1904000) negative regulation of energy homeostasis(GO:2000506) |
0.1 | 0.6 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 1.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:0015734 | taurine transport(GO:0015734) |
0.1 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.8 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.6 | GO:0051585 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.1 | 0.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 1.0 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 2.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 1.9 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 1.1 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 1.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.3 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 1.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.4 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.5 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.3 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.4 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.3 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 0.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 2.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 5.2 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.1 | 0.9 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.9 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 1.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 2.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.4 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:1903971 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 0.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 1.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 2.0 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 5.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 1.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.2 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
0.1 | 0.2 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 7.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 1.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 1.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 1.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.0 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 1.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.7 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.3 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 4.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.3 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.0 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 1.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 1.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.2 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 5.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.0 | 0.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.0 | 0.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 2.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.6 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0002705 | positive regulation of leukocyte mediated immunity(GO:0002705) |
0.0 | 0.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.0 | 0.9 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 2.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 1.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 8.8 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 2.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.3 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.0 | 0.1 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.2 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.3 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.6 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.0 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) histone H3-R2 methylation(GO:0034970) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.3 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.1 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 1.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0010157 | response to chlorate(GO:0010157) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 9.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 4.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 1.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 11.1 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.3 | 16.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 1.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.2 | 3.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 2.2 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 2.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.2 | 1.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 3.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 1.4 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 4.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 2.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.6 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 4.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.3 | GO:0030892 | mitotic cohesin complex(GO:0030892) |
0.1 | 1.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 7.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 5.6 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 6.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.1 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 2.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 7.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 1.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 1.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 7.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 2.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.0 | 2.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 5.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 2.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0002141 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.0 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 4.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 2.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 11.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.7 | 3.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.7 | 5.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.6 | 1.8 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.5 | 1.6 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.5 | 1.9 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.5 | 3.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 4.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.4 | 3.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 2.5 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.3 | 1.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.3 | 1.0 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.3 | 17.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 3.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.3 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.2 | 1.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 1.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.6 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.2 | 3.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 1.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 4.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 5.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 0.5 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.2 | 1.0 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 0.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 3.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 4.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 29.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.7 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 2.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 0.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.3 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.4 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.1 | 0.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.1 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.4 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
0.1 | 0.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 1.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 3.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.5 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.3 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 10.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 1.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.1 | 0.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.0 | 0.2 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.0 | 0.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 1.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 2.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.0 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.0 | 1.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 3.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 2.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 5.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 1.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.1 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.0 | 1.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 2.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 3.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 1.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 6.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 1.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 2.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 2.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 2.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 4.0 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.0 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.0 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 2.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 4.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 8.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 9.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 10.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 10.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 4.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 3.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 2.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 8.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 5.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 18.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 5.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 4.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 4.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 2.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 3.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 3.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 2.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |